Testing a new drug for advanced solid tumors
Part of Cancer, Lungs & breathing clinical trials.
This trial tests an investigational drug (BMS-986463) in people with advanced solid tumors. It aims to find a safe dose and see if it helps shrink or control the cancer. You must be well enough to do daily activities and have a tumor that can be biopsied before treatment starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to care for yourself and do light daily activities (performance status 0 or 1).
- You need to have at least one tumor that can be safely biopsied (sampled) before treatment, separate from the main tumor being tracked.
- Your cancer must be advanced (cannot be surgically removed or has spread) and confirmed as a carcinoma.
- You cannot have cancer that has spread to the lining of the brain or spinal cord (leptomeningeal disease).
- You must not have another active cancer requiring treatment, or a history of other cancer in the last 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug (BMS-986523) alone or with other cancer treatments for people with advanced solid tumors that have a specific change in the KRAS gene. It aims to see if the drug is safe and effective.
This trial is testing a new drug (BMS-986517) for people with advanced solid tumors, including certain lung, head and neck, and breast cancers. The goal is to see if the drug is safe and effective.
This study tests a new drug (BMS-986482) alone or with other treatments for people with advanced solid tumors that haven't responded to standard therapies. The goal is to see if this drug can shrink tumors or slow their growth.
This trial tests a new drug called MGC026 that targets a protein called B7-H3 on cancer cells, aiming to shrink or slow different advanced solid tumors. It is an early-phase study to find the right dose and check safety.
This trial tests different doses of a new drug (BI 3820768) in people with advanced solid tumors, specifically germ cell tumors, endometrial cancer, or ovarian cancer. The goal is to see if the drug is safe and how well it works.
This trial tests a new drug called SMP-3124LP for people with advanced solid tumors that no longer respond to standard treatments. It is given in two phases: first to find the best dose (dose escalation) and then to see how well it works in specific cancer types (dose expansion).
Hear when a new High-grade Serous Ovarian Carcinoma (HGSOC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.